Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
None listed
Sponsors
DR S R Rajasthan Ayurved University Jodhpur
Eligibility
Inclusion criteria
Inclusion criteria: • Patients with conditions traditionally treated by Agnikarma, such as joint pain, arthritis, sciatica, muscular spasms. • Individuals with chronic pain unresponsive to other therapies, suitable for heat-based treatments. • Participants aged between 18 to 65 years. • Patients with stable conditions like diabetes or hypertension, without severe heat sensitivity or skin disorders. • Individuals who provide informed consent and agree to follow-up assessments. • Patients willing to undergo Agnikarma with electronically controlled devices. • Ayurvedic practitioners trained in traditional Agnikarma, willing to adopt electronically controlled methods.
Exclusion criteria
Exclusion criteria: • Patients with severe skin conditions, burns, infections, or heat intolerance. • Pregnant or lactating women due to potential risks. • Patients with uncontrolled chronic illnesses like cardiac disease, advanced diabetes, or those with compromised immune systems; individuals on anticoagulant therapy. • Subjects with severe psychiatric disorders or cognitive impairments affecting consent or protocol adherence. • Individuals with a history of adverse reactions to Agnikarma. • Patients unwilling to participate in electronically controlled Agnikarma or follow research protocols.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Data generation on Effectiveness and safety of electronically controlled Agnikarma DeviceTimepoint: Weekly | — |
Secondary
| Measure | Time frame |
|---|---|
| o Assess the time efficiency, ease of use, and consistency of electronically controlled Agnikarma devices versus traditional methods. o Conduct a cost-benefit analysis to determine if the new technology offers improved outcomes and value over time. o Measure practitioner acceptance and ease of integrating electronic devices into clinical practice. o Monitor long-term patient outcomes to evaluate sustained therapeutic benefits and recurrence rates compared to traditional Agnikarma. Timepoint: 6 Months | — |
Countries
India
Contacts
Public ContactDr. Vishnu Dutt Sharma
Dr. S.R. Rajasthan Ayurved University, Jodhpur
Outcome results
None listed